More Percheron Therapeutics Limited news Percheron Therapeutics LimitedASX: PER ATL1102 for DMD EMA PIP feedback and FDA regulatory progress Jun 22, 2021 at 3:29 AM UTC · Issued by Percheron Therapeutics Limited As issuedPlain English Percheron Therapeutics Limited has released a press release. View Attachment